Reproductive performance of women with uterine anomalies. An evaluation of 182 cases.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 7113692)

Published in Acta Obstet Gynecol Scand on January 01, 1982

Authors

P K Heinonen, S Saarikoski, P Pystynen

Articles by these authors

Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod (2001) 2.28

Chlamydial endometritis. J Clin Pathol (1985) 1.80

Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65

Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1989) 1.62

Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis (1994) 1.61

Dissemination of endometrial cells during carbon dioxide hysteroscopy and chromotubation among infertile patients. Fertil Steril (1990) 1.54

Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril (1996) 1.47

Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46

Infertility and coeliac disease. Gut (1996) 1.45

Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41

Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol (1999) 1.38

Weights of placentae from small-for-gestational age infants revisited. Placenta (2001) 1.32

High and unchanged sperm counts of Finnish men. Int J Androl (1996) 1.27

Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26

Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women. Calcif Tissue Int (1994) 1.24

Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation. Genitourin Med (1993) 1.23

Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol (1989) 1.20

Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol (1986) 1.20

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol (1997) 1.18

Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17

Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17

The influence of perinatal factors on breast feeding. Acta Paediatr Scand (1983) 1.16

Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet (1985) 1.13

Comparison of endometrial biopsy and peritoneal fluid cytologic testing with laparoscopy in the diagnosis of acute pelvic inflammatory disease. Am J Obstet Gynecol (1985) 1.10

Malignant fibrous histiocytoma of the vulva. Gynecol Oncol (1987) 1.10

Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10

Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol (1993) 1.10

Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09

Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol (1985) 1.09

Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis (1990) 1.09

The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas (1995) 1.09

Spontaneous luteinizing hormone surge and cleavage of in vitro fertilized embryos. Fertil Steril (1988) 1.08

Uterus didelphys: a report of 26 cases. Eur J Obstet Gynecol Reprod Biol (1984) 1.07

Birth weight and sex of children and the correlation to the body burden of PCDDs/PCDFs and PCBs of the mother. Environ Health Perspect (1998) 1.06

Clinical implications of the unicornuate uterus with rudimentary horn. Int J Gynaecol Obstet (1983) 1.06

Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis (1984) 1.05

Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05

Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis (1997) 1.05

Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis (1992) 1.05

Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol (1999) 1.04

Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol (1994) 1.03

Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03

PCDD, PCDF, and PCB concentrations in human milk from two areas in Finland. Chemosphere (1997) 1.03

Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int (2000) 1.03

Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy. Genitourin Med (1991) 1.02

Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study. Ann Rheum Dis (1994) 1.01

Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women. Osteoporos Int (1998) 1.01

Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis (1997) 1.01

Perinatal diagnostic evaluation of velamentous umbilical cord insertion: clinical, Doppler, and ultrasonic findings. Obstet Gynecol (1996) 1.01

Factors associated with progression of cervical human papillomavirus (HPV) infections into carcinoma in situ during a long-term prospective follow-up. Br J Obstet Gynaecol (1988) 0.99

Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res (2000) 0.98

Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab (1999) 0.98

Finnish national register of laparoscopic hysterectomies: a review and complications of 1165 operations. Am J Obstet Gynecol (1997) 0.97

Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow-up of 513 women for two years. Eur J Gynaecol Oncol (1987) 0.97

p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer (1999) 0.97

Risk factors for perimenopausal distal forearm fracture. Osteoporos Int (2000) 0.96

Cytomegalovirus hepatitis in late pregnancy. Int J Gynaecol Obstet (1992) 0.96

Fractures and low axial bone density in perimenopausal women. J Clin Epidemiol (1995) 0.94

Activities of aspartate and alanine aminotransferases and alkaline phosphatase in sera of healthy subjects. Scand J Clin Lab Invest (1975) 0.94

HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas (1998) 0.93

Amniotic fluid U. urealyticum colonization: significance for maternal peripartal infections at term. Am J Perinatol (1997) 0.93

Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol (1996) 0.93

Prospective follow-up of genital HPV infections: survival analysis of the HPV typing data. Eur J Epidemiol (1990) 0.93

Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res (1995) 0.93

Antigen specific serum antibody response to Chlamydia trachomatis in patients with acute pelvic inflammatory disease. J Clin Pathol (1990) 0.92

A novel organotypic culture model for normal human endometrium: regulation of epithelial cell proliferation by estradiol and medroxyprogesterone acetate. Hum Reprod (2005) 0.92

Lead, magnesium, selenium and zinc in human seminal fluid: comparison with semen parameters and fertility. Hum Reprod (1987) 0.92

Elevated levels of a somatomedin-binding protein PP12 in patients with ovarian cancer. Cancer (1986) 0.92

Polymerase chain reaction amplification of human papillomavirus DNA from archival, Papanicolaou-stained cervical smears. Acta Cytol (1996) 0.92

Risk of obstetric cholestasis in sisters of index patients. Clin Genet (2001) 0.92

Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate (2001) 0.92

Evolution of human papillomavirus infections in the uterine cervix during a long-term prospective follow-up. Appl Pathol (1987) 0.91

Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol (1973) 0.91

Tumour-associated antigen CA 125 in patients with ovarian cancer. Br J Obstet Gynaecol (1985) 0.90

Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix. Eur J Epidemiol (1985) 0.90

Serum C-reactive protein determination in acute pelvic inflammatory disease. Am J Obstet Gynecol (1986) 0.90

Risks of perimenopausal fractures--a prospective population-based study. Acta Obstet Gynecol Scand (1995) 0.89

Accumulation of cadmium, zinc, and copper in maternal blood and developmental placental tissue: differences between Finland, Estonia, and St. Petersburg. Environ Res (2000) 0.89

Transvaginal ultrasound in the diagnosis and treatment of tubo-ovarian abscess. Br J Obstet Gynaecol (1990) 0.89

Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer. Tumour Biol (2007) 0.89

Early pregnancy loss and exposure to 50-Hz magnetic fields. Bioelectromagnetics (1993) 0.89

Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Calcif Tissue Int (1998) 0.88

Lifestyle and other factors predict ankle fractures in perimenopausal women: a population-based prospective cohort study. Bone (2002) 0.88

Induction of labour with sulprostone after foetal death and in hydatidiform mole. Prostaglandins (1980) 0.88

Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women--the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas (1993) 0.88

Clinical course and prognostic factors of human papillomavirus infections in men. Sex Transm Dis (1995) 0.88

Placental glucose transporters in fetal intrauterine growth retardation and macrosomia. Gynecol Obstet Invest (1997) 0.88

C-reactive protein (CRP) levels after normal and complicated caesarean section. Ann Chir Gynaecol (1989) 0.88

Endometritis and acute salpingitis associated with Chlamydia trachomatis and herpes simplex virus type two. Obstet Gynecol (1985) 0.87

Intrapartum rupture of uterus diagnosed by ultrasound: a case report. Int J Gynaecol Obstet (1984) 0.87

Deletion in the FMR1 gene in a fragile-X male. Am J Med Genet (1996) 0.87

Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. Maturitas (1995) 0.87

Microbiology of Bartholin's duct abscess. Infect Dis Obstet Gynecol (1994) 0.87

Systemic alpha-interferon (Wellferon) treatment of genital human papillomavirus (HPV) type 6, 11, 16, and 18 infections: double-blind, placebo-controlled trial. Gynecol Oncol (1991) 0.86

The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women. J Bone Miner Res (2000) 0.86

Second laparoscopy after treatment of acute pelvic inflammatory disease. Obstet Gynecol (1987) 0.86

Smoking does affect fecundity. Eur J Obstet Gynecol Reprod Biol (1990) 0.86